✦ LIBER ✦

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia

✍ Scribed by Rosemary Sutton; Nicola C. Venn; Jonathan Tolisano; Anita Y. Bahar; Jodie E. Giles; Lesley J. Ashton; Lochie Teague; Gemma Rigutto; Keith Waters; Glenn M. Marshall; Michelle Haber; Murray D. Norris; Australian; New Zealand Children’s Oncology Group

Book ID: 108676348
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 204 KB
Volume: 146
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.07744.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro cellular drug sensitivity at di

In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

✍ Gudmar Lönnerholm; Ingrid Thörn; Christer Sundström; Britt-Marie Frost; Jonas Ab 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 370 KB

Predictive value of flow cytometric mini

Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy – results from a single UK centre

✍ Jayashree Motwani; Jenny Jesson; Elaine Sturch; Sue Jones; Lisa Eyre; Phil Short 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

A demographic study of the clinical sign

A demographic study of the clinical significance of minimal residual disease in children with acute lymphoblastic leukemia

✍ Levett, D. ;Middleton, P. ;Cole, M. ;Reid, M.M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## Background Minimal residual disease (MRD) detected during remission might predict outcome in children with acute lymphoblastic leukemia. No population‐based studies have been carried out. We studied all children with ALL presenting over 5 years within a defined population to determi

Minimal residual disease detection in ch

Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches

✍ Jacqueline Ryan; Fiona Quinn; Armelle Meunier; Ludmila Boublikova; Mireille Cram 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB